Cherry Bekaert audit partner facing SEC scrutiny over MiMedx fraud case


The Securities and Exchange Commission is considering whether to pursue enforcement against a certified public accountant for his alleged role in an accounting fraud case the agency brought against biotech company MiMedx Group.

This is Members-only content
To continue reading, choose one of the options below: